{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:50:53Z","timestamp":1769813453654,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ygyno.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T09:17:28Z","timestamp":1368263848000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer"],"prefix":"10.1016","volume":"130","author":[{"given":"Gretchen","family":"Glaser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.05.007_bb0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0010","first-page":"766","article-title":"Ovarian cancer. Clinical practice guidelines in oncology","volume":"6","author":"Morgan","year":"2008","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0020","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"issue":"676","key":"10.1016\/j.ygyno.2013.05.007_bb0025","first-page":"e1","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2007.03.008","article-title":"Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer","volume":"106","author":"Geisler","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1477-2574.2011.00417.x","article-title":"Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data","volume":"14","author":"Moreno Elola-Olaso","year":"2012","journal-title":"HPB"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2214\/ajr.165.4.7676985","article-title":"Ovarian carcinoma: value of CT in predicting success of debulking surgery","volume":"165","author":"Meyer","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.06.054","article-title":"Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer","volume":"96","author":"Qayyum","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography \u2014 a prospective study","volume":"108","author":"Risum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00330-009-1533-0","article-title":"Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer","volume":"20","author":"Jung","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00404-011-1864-3","article-title":"Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer","volume":"284","author":"Fujwara","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0095","first-page":"4043","article-title":"Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer","volume":"31","author":"Gerestein","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0100","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2009.03.002","article-title":"A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer","volume":"35","author":"Gemer","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.2000.5749","article-title":"The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma","volume":"77","author":"Chi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1525-1438.2003.13019.x","article-title":"CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer","volume":"13","author":"Memarzadeh","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ajog.2004.02.005","article-title":"Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays","volume":"190","author":"Berchuck","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00330-002-1712-8","article-title":"Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer","volume":"13","author":"Ricke","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/0284186X.2010.500296","article-title":"Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer","volume":"50","author":"Risum","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2013.05.007_bb0130","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813007403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813007403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T16:06:31Z","timestamp":1595779591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813007403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0090825813007403"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.05.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}